HER2 borderline is a negative prognostic factor for primary malignant breast cancer. Bhattacharjee A, Rajendra J, Dikshit R, Dutt S, et al. Breast Cancer Res Treat 2020 Mar 31. pii: 10.1007/s10549-020-05608.

Read + Share

Amedeo Smart

Independent Medical Education

Bhattacharjee A, Rajendra J, Dikshit R, Dutt S, et al. HER2 borderline is a negative prognostic factor for primary malignant breast cancer. Breast Cancer Res Treat 2020 Mar 31. pii: 10.1007/s10549-020-05608.
PMID: 32236825